Successful Treatment of Adult Onset Langerhans Cell Histiocytosis with Multi-Drug Combination Therapy
スポンサーリンク
概要
- 論文の詳細を見る
Adult onset Langerhans cell histiocytosis (LCH) is a rare disorder. Its clinical features have been well described in children, however remain poorly defined in adults. Optimal treatment strategy is still under debate. We have encountered two cases of adult onset LCH, which obtained a durable disease control by combination chemotherapy using prednisone, vinblastine and 6-mercaptopurine. Herein, we report their clinical features together with a review of the current literature.
著者
-
Okamoto Shinichiro
Division Of Hematology Department Of Internal Medicane Keio University School Of Medicine
-
Yokoyama Kenji
Division Of Hematology Department Of Medicine Keio University School Of Medicine
-
MATSUKI Eri
Division of Hematology, Department of Medicine, Keio University School of Medicine
-
Nakaya Aya
Department of Internal Medicine, Hiratsuka City Hospital
-
Tsukada Yuiko
Division of Hematology, Department of Internal Medicine, Keio University School of Medicine, Japan
関連論文
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
- Long-term Follow-up of Allogeneic Bone Marrow Transplantation after Reduced-Intensity Conditioning in Patients with Chronic Myelogenous Leukemia in the Chronic Phase
- Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan
- Aplastic Anemia
- Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
- Non-Tuberculous Mycobacterial Infection Localized in Small Intestine Developing after Allogeneic Bone Marrow Transplantation
- Gelatinous Degeneration in a Recipient of Allogeneic Bone Marrow Transplantation
- Overcoming the effect of rifampin on the tacrolimus metabolism by itraconazole administration in an allogeneic hematopoietic stem cell transplant recipient
- Drug interaction between oral solution itraconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplantation recipients : an association with bioavailability of oral solution itraconazole
- Prevention of Cytomegalovirus Infection by Valaciclovir after Allogeneic Bone Marrow Transplantation from an Unrelated Donor
- Risk-Adapted Preemptive Therapy for Cytomegalovirus Diseases after Allogeneic Hematopoietic Stem Cell Transplantation
- A Flare-Up of Chronic Graft-versus-Host Disease of the Liver That Mimics Acute Hepatitis in a Recipient of an Allogeneic Peripheral Blood Stem Cell Transplant
- Thalidomide-Induced Severe Neutropenia during Treatment of Multiple Myeloma
- Efficacy of mouth rinse in preventing oral mucositis in patients receiving high-dose cytarabine for allogeneic hematopoietic stem cell transplantation
- Esophageal varices and portal hypertensive gastropathy associated with hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation
- Recurrence of Autoimmune Disease after Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma
- Multilineage Involvement of Light Microscopic Myeloperoxidase-Negative Acute Leukemia
- Granisetron plus Dexamethasone versus Granisetron Alone in the Prevention of Vomiting Induced by Conditioning for Stem Cell Transplantation : A Prospective Randomized Study
- Thalidomide for the Treatment of Refractory Multiple Myeloma : Association of Plasma Concentrations of Thalidomide and Angiogenic Growth Factors with Clinical Outcome
- Elevated Level of Plasma Basic Fibroblast Growth Factor in Multiple Myeloma Correlates with Increased Disease Activity
- Current and future perspectives on the TARGET system : the registration system for Glivec^【○!R】 established by the JSH
- Central line-associated bacteremia caused by drug-resistant Staphylococcus caprae after chemotherapy for acute myelogenous leukemia
- An Adult Patient With Hypersensitivity to Mosquito Bites Developing Mantle Cell Lymphoma
- Low prevalence of activated protein C resistance and coagulation factor V Arg^ to Gln mutation among Japanese patients with various forms of thrombosis, and normal individuals
- Successful Treatment of Adult Onset Langerhans Cell Histiocytosis with Multi-Drug Combination Therapy
- Hemorrhagic colonic ulcers caused by dasatinib for chronic myelogenous leukemia
- Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
- Erythroid Crisis Caused by Parvovirus B19 Transmitted Via Red Blood Cell Transfusion
- The cell cycle regulator Cdh1 controls the pool sizes of hematopoietic stem cells and mature lineage progenitors by protecting from genotoxic stress
- The role of a real-time PCR technology for rapid detection and identification of bacterial and fungal pathogens in whole-blood samples
- Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria : the AEGIS Clinical Trial
- Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation
- Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients : a double-blind, randomized Phase III clinical trial
- Discrepancy in the kinetics of total and active anti-thymocyte globulin blood concentrations in recipients of allogeneic hematopoietic stem cell transplantation
- Oral ribavirin therapy for lower respiratory tract infection of respiratory syncytial virus complicating bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation
- Prospective study of combination therapy with low-dose thalidomide plus prednisolone ameliorating cytopenia in primary myelofibrosis
- Prevention of cytarabine-induced kerato-conjunctivitis by eye rinse in patients receiving high-dose cytarabine and total body irradiation as a conditioning for hematopoietic stem cell transplantation
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Drug interaction between voriconazole and tacrolimus and its association with the bioavailability of oral voriconazole in recipients of allogeneic hematopoietic stem cell transplantation
- Pancytopenia due to pyrimethamine triggered by transplant-associated microangiopathy after allogeneic bone marrow transplantation
- An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)
- Post-transplant consolidation therapy using thalidomide alone for the patients with multiple myeloma : a feasibility study in Japanese population
- Itraconazole may increase the risk of early-onset bortezomib-induced peripheral neuropathy
- Transformation of Myelodysplastic Syndrome to Acute Lymphoblastic Leukemia : A Case Report and Review of the Literature
- Validation of NIH consensus criteria for diagnosis and severity-grading of chronic graft-versus-host disease